Skip to main content

Advertisement

Log in

Obstruction-Free Survival Following Operative Intervention for Malignant Bowel Obstruction in Appendiceal Cancer

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Patients with peritoneal metastases from appendiceal cancer are at high risk of malignant bowel obstruction (MBO), which is associated with significant morbidity and mortality. There are no definitive treatment guidelines regarding operative intervention for MBO. We sought to evaluate the efficacy and safety of operative intervention in this population.

Methods

We identified patients with peritoneal metastases from appendiceal cancer who underwent surgery for MBO at our institution between 2011 and 2018. Baseline characteristics, postoperative complications, and follow-up data were collected. The primary endpoint was obstruction-free survival (OFS). Other endpoints were postoperative recovery of bowel function, 60-day Clavien–Dindo (CD) morbidity, and overall survival (OS).

Results

Twenty-six patients underwent operative treatment for MBO, of whom 14 had high-grade (HG) histology and 12 had low-grade (LG) histology. Seven (25.9%) patients had severe (CD grade 3 or higher) 60-day complications, including one (3.8%) postoperative death. All remaining patients had return of bowel function and resumed oral intake during hospitalization. Six (23.1%) patients had repeat admissions for MBO after surgery. Median OFS was 17.0 months (95% confidence interval [CI] 2.3–31.8), and median OS was 18.5 months (95% CI 3.6–33.3) following surgery.

Conclusion

In this carefully selected group of patients with peritoneal metastases from appendiceal cancer, surgery for MBO provided durable palliation with acceptable morbidity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Chakraborty A, Selby D, Gardiner K, Myers J, Moravan V, Wright F. Malignant bowel obstruction: natural history of a heterogeneous patient population followed prospectively over two years. J Pain Symptom Manag. 2011;41(2):412–420.

    Article  PubMed  Google Scholar 

  2. Feuer DJ, Broadley KE, Shepherd JH, Barton DP. Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev. 2000;(4):CD002764.

  3. Francescutti V, Miller A, Satchidanand Y, Alvarez-Perez A, Dunn KB. Management of bowel obstruction in patients with stage IV cancer: predictors of outcome after surgery. Ann Surg Oncol. 2013;20(3):707–714.

    Article  PubMed  Google Scholar 

  4. Wong TH, Tan YM. Surgery for the palliation of intestinal obstruction in advanced abdominal malignancy. Singap Med J. 2009;50(12):1139–1144.

    CAS  Google Scholar 

  5. Henry JC, Pouly S, Sullivan R, et al. A scoring system for the prognosis and treatment of malignant bowel obstruction. Surgery. 2012;152(4):747–756; discussion 756–747.

  6. Hwang M, Pirrello R, Pu M, Messer K, Roeland E. Octreotide prescribing patterns in the palliation of symptomatic inoperable malignant bowel obstruction patients at a single US academic hospital. Support Care Cancer. 2013;21(10):2817–2824.

    Article  PubMed  Google Scholar 

  7. Soriano A, Davis MP. Malignant bowel obstruction: individualized treatment near the end of life. Cleve Clin J Med. 2011;78(3):197–206.

    Article  PubMed  Google Scholar 

  8. Dolan EA. Malignant bowel obstruction: a review of current treatment strategies. Am J Hosp Palliat Care. 2011;28(8):576–582.

    Article  PubMed  Google Scholar 

  9. Roeland EJ. Managing malignant bowel obstruction: moving beyond drip and suck. J Oncol Pract. 2017;13(7):437–438.

    Article  PubMed  Google Scholar 

  10. Pujara D, Chiang YJ, Cormier JN, Bruera E, Badgwell B. Selective approach for patients with advanced malignancy and gastrointestinal obstruction. J Am Coll Surg. 2017;225(1):53–59.

    Article  PubMed  Google Scholar 

  11. Paul Olson TJ, Pinkerton C, Brasel KJ, Schwarze ML. Palliative surgery for malignant bowel obstruction from carcinomatosis: a systematic review. JAMA Surg. 2014;149(4):383–392.

    Article  PubMed  PubMed Central  Google Scholar 

  12. White SI, Abdool SI, Frenkiel B, Braun WV. Management of malignant left-sided large bowel obstruction: a comparison between colonic stents and surgery. ANZ J Surg. 2011;81(4):257–260.

    Article  PubMed  Google Scholar 

  13. Santangelo ML, Grifasi C, Criscitiello C, et al. Bowel obstruction and peritoneal carcinomatosis in the elderly. A systematic review. Aging Clin Exp Res. 2017;29 Suppl 1:73–78.

  14. Shaib WL, Goodman M, Chen Z, et al. Incidence and survival of appendiceal mucinous neoplasms: a SEER analysis. Am J Clin Oncol. 2017;40(6):569–573.

    Article  PubMed  Google Scholar 

  15. Ihemelandu C, Fernandez S, Sugarbaker PH. A prognostic model for predicting overall survival in patients with peritoneal surface malignancy of an appendiceal origin treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2017;24(8):2266–2272.

    Article  PubMed  Google Scholar 

  16. World Health Organization Classification of Tumours of the Digestive Tract. Vol 3. 4th ed. Lyon: IARC Press; 2010

    Google Scholar 

  17. Carr NJ, Cecil TD, Mohamed F, et al. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal Neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified delphi process. Am J Surg Pathol. 2016;40(1):14–26.

    Article  PubMed  Google Scholar 

  18. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Folkert IW, Roses RE. Value in palliative cancer surgery: a critical assessment. J Surg Oncol. 2016;114(3):311–315.

    Article  PubMed  Google Scholar 

  20. Asare EA, Compton CC, Hanna NN, et al. The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: analysis of the national cancer data base. Cancer. 2016;122(2):213–221.

    Article  PubMed  Google Scholar 

  21. SWOG. SWOG Study S1316. Prospective comparative effectiveness trial for malignant bowel obstruction. 2017. Available at: http://swog.org/Visitors/S1316/.

Download references

Acknowledgment

This study was supported by a University of California San Diego Clinical and Translational Research Institute Grant (UL1TR001442).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joel M. Baumgartner MD, MAS.

Ethics declarations

Disclosures

Joel M. Baumgartner, Rebecca Marmor, Athena Hsu, Jula Veerapong, Kaitlyn J. Kelly, and Andrew M. Lowy have no disclosures or relevant conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baumgartner, J.M., Marmor, R., Hsu, A. et al. Obstruction-Free Survival Following Operative Intervention for Malignant Bowel Obstruction in Appendiceal Cancer. Ann Surg Oncol 26, 3611–3617 (2019). https://doi.org/10.1245/s10434-019-07507-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-019-07507-4

Navigation